Subconjuntival injection of expanded allogenic adult adipose tissue-derived mesenchymal stem cells (ASC

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Subconjuntival injection of expanded allogenic adult adipose tissue-derived mesenchymal stem cells (ASC
Treatment and conditionWhere it standsTrials
Subconjuntival injection of expanded allogenic adult adipose tissue-derived mesenchymal stem cells (ASC for dry eye syndromesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Subconjuntival injection of expanded allogenic adult adipose tissue-derived mesenchymal stem cells (ASC for graft vs host diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1